Kyverna Therapeutics Investors Can Join Class Action Against Company

BENSALEM, Pa., Dec. 23, 2024 /PRNewswire/ — The Law Offices of Howard G. Smith has announced an opportunity for investors who suffered significant losses in Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) KYTX to take the lead in a securities fraud class action lawsuit.

Understanding the Class Period and Deadlines

Class Period: February 2024 IPO
Lead Plaintiff Deadline: February 7, 2025

How to Get Involved

If you are among those who have lost money on Kyverna investments, you are encouraged to reach out to the Law Offices of Howard G. Smith at 215-638-4847 or via email at [email protected] to discuss your legal options.

Details of the Allegations

The complaint claims that throughout the Class Period, the Defendants failed to inform investors about critical negative data related to one of the Company’s trials. Specific concerns include: (1) undisclosed adverse trial data; (2) potential risks from withholding such data; and (3) misleading positive statements regarding the Company’s operations and future prospects that lacked a reasonable foundation.

Your Rights as an Investor

To be part of the class action lawsuit, you don’t need to take any immediate action. You can either hire a lawyer of your choice or choose to remain an absent member of the class. For more information about this class action or any questions regarding your rights or interests, please contact Howard G. Smith, Esquire, at the Law Offices of Howard G. Smith, located at 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020. You can also reach him by phone at (215) 638-4847 or through email at [email protected], or visit www.howardsmithlaw.com.